Evaluation of the MC4R gene across eMERGE network identifies many unreported obesity-associated variants
Background/Objectives Melanocortin-4 receptor (MC4R) plays an essential role in food intake and energy homeostasis. More than 170 MC4R variants have been described over the past two decades, with conflicting reports regarding the prevalence and phenotypic effects of these variants in diverse cohorts...
Gespeichert in:
Veröffentlicht in: | International Journal of Obesity 2021, Vol.45 (1), p.155-169 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background/Objectives
Melanocortin-4 receptor (MC4R) plays an essential role in food intake and energy homeostasis. More than 170
MC4R
variants have been described over the past two decades, with conflicting reports regarding the prevalence and phenotypic effects of these variants in diverse cohorts. To determine the frequency of
MC4R
variants in large cohort of different ancestries, we evaluated the
MC4R
coding region for 20,537 eMERGE participants with sequencing data plus additional 77,454 independent individuals with genome-wide genotyping data at this locus.
Subjects/Methods
The sequencing data were obtained from the eMERGE phase III study, in which multisample variant call format calls have been generated, curated, and annotated. In addition to penetrance estimation using body mass index (BMI) as a binary outcome, GWAS and PheWAS were performed using median BMI in linear regression analyses. All results were adjusted for principal components, age, sex, and sites of genotyping.
Results
Targeted sequencing data of
MC4R
revealed 125 coding variants in 1839 eMERGE participants including 30 unreported coding variants that were predicted to be functionally damaging. Highly penetrant unreported variants included (L325I, E308K, D298N, S270F, F261L, T248A, D111V, and Y80F) in which seven participants had obesity class III defined as BMI ≥ 40 kg/m
2
. In GWAS analysis, in addition to known risk haplotype upstream of
MC4R
(best variant rs6567160 (
P
= 5.36 × 10
−25
, Beta = 0.37), a novel rare haplotype was detected which was protective against obesity and encompassed the V103I variant with known gain-of-function properties (
P
= 6.23 × 10
−08
, Beta = −0.62). PheWAS analyses extended this protective effect of V103I to type 2 diabetes, diabetic nephropathy, and chronic renal failure independent of BMI.
Conclusions
MC4R
screening in a large eMERGE cohort confirmed many previous findings, extend the
MC4R
pleotropic effects, and discovered additional
MC4R
rare alleles that probably contribute to obesity. |
---|---|
ISSN: | 0307-0565 1476-5497 1476-5497 |
DOI: | 10.1038/s41366-020-00675-4 |